课题基金 / 基金详情

项目摘要

项目成果

LARRY M KARNITZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The integrity of our genomes is under continual assault from errors generated during replication, metabolically produced reactive oxygen species, spontaneous depurination, and endogenous and exogenous agents that damage DNA. Replication stress and DNA damage activate checkpoint signaling pathways that help maintain gemonic stability by orchestrating DNA repair, gene transcription, and cell cycle arrest. A critical check point signaling pathway is the Atr-Chkl signaling pathway, which is activated by replication stress and other types of DNA damage and plays an important role in maintaining genomic stability. Key partcipants in the Atr-Chkl signaling pathway are Rad9, Husl, and Radl, which form a Rad9- Husl-Radl (911) complex, and are required for optimal Chkl activation as well as other cellular responses to DNA damage. The 911 complex forms a PCNA-like clamp that is loaded around DNA at sites of damage. Although the clamp is loaded around DNA and is required for optimal Chkl activation, the clamp's actual role in Chkl activation and orchestrating other cellular events remains unknown. In Aim 1 of this proposal, we have identified a novel Rad9-interacting protein that binds the C terminus of Rad9, a region required for Chkl activation, and we propose to examine the role of this interacting protein on Rad9 function and Chkl activation. In Aim 2, we describe Rad9B, a new Rad9 paralog, and demonstrate that Rad9, Rad9B, Husl, HuslB (a Husl paralog), and Radl combinatorially assemble into different clamps. We then propose to examine the roles of each subunit in cellular responses to a panel of genotoxic agents to identify whether each 911 subunit has unique and/or overlapping roles. In Aim 3, we show that the 911 complex interacts with a translesion DNA polymerase and we propose experiments to examine the role of 911 subunits in translesion polymerase function. Collectively, these studies will provide new insights into how the 911 complexes direct downstream events that regulate checkpoint activation, cell survival, and genomic stability.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1083/jcb.200804042
发表时间: 2008-11-03
期刊: The Journal of cell biology
影响因子: --
作者: [Leonard JM, Ye H, Wetmore C, Karnitz LM]
通讯作者: Karnitz LM
Targeting Chk1 in Acute Myeloid Leukemia
  • 批准号:
    9297247
  • 项目类别:
  • 资助金额:
    $36.37万
  • 财政年份:
    2015
  • 负责人:
    LARRY M KARNITZ
  • 依托单位:
Targeting Chk1 in Acute Myeloid Leukemia
  • 批准号:
    9115542
  • 项目类别:
  • 资助金额:
    $36.37万
  • 财政年份:
    2015
  • 负责人:
    LARRY M KARNITZ
  • 依托单位:
CDK12 in Ovarian Cancer
  • 批准号:
    9035009
  • 项目类别:
  • 资助金额:
    $38.4万
  • 财政年份:
    2015
  • 负责人:
    LARRY M KARNITZ
  • 依托单位:
Project 3: Repurposing Ceritinib for Ovarian Cancer Therapy
  • 批准号:
    10452721
  • 项目类别:
  • 资助金额:
    $23.66万
  • 财政年份:
    2009
  • 负责人:
    LARRY M KARNITZ
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: